Lonza launches the PyroCell Monocyte Activation Test System for reliable and sustainable <i>in vitro</i> pyrogen testing
5 Oct 2020
Lonza Bioscience has announced the commercial release of the PyroCell™ MAT System, a sustainable and reliable solution for in vitro pyrogen testing. The new offering expands upon Lonza’s experience in primary cells and endotoxin testing, combined with Sanquin’s expertise in MAT production, helping ensure the safety of parenteral pharmaceuticals during development, manufacture, and product release.
The PyroCell™ MAT System provides advantages over existing methods for pyrogen detection in complex formulations, such as human vaccines and cell-based biologics. It provides sensitive pyrogen detection without the use of experimental animals, thereby supporting sustainability objectives while helping to deliver safe products to the market.
Through a collaboration with Sanquin Reagents B.V., Lonza’s PyroCell™ MAT System is comprised of pooled, cryopreserved Peripheral Blood Mononuclear Cells (PBMCs) specifically developed for use with the MAT. These cryopreserved PyroCell™ Kit PBMCs eliminate the need to qualify blood donors and undertake cell isolation for each single test run. With the PyroCell™ MAT System, the cells can be available on demand whenever the need arises.
The PyroCell™ MAT System reagents can now be purchased throughout North America and Europe through Lonza’s comprehensive distribution network and sales support services.
Want the latest science news straight to your inbox? Become a SelectScience member for free today>>
Related Products
Request Quote for All Products
Nucleofector® II Device
Lonza Group LtdThe basic Nucleofector® II Device is a single cuvette based system that has been used in research labs since 2001. It allows efficient transfection of hard-to-transfect cell lines and primary cells with different substrates, e.g. DNA vectors or siRNA oligonucleotides, in low throughput format. What benefits are important for your work? Efficient transfection in single cuvette format? Up to 90% efficiency with plasmid DNA Up to 99% efficiency with siRNA duplexes Also suited for peptides, proteins or small molecules Reliable easy-to-use technology? More than 150 ready-to-use Amaxa® Optimized Protocols High viability and preservation of cell funcionality Data for more than 650 cell types in our Cell Database Consumables tailored to your needs? Nucleofector® Kits are available in low (10 reactions), normal (25 reactions) and high (100 reactions) usage format More than 50 dedicated primary cell kits available A collection of 5 cell line kits and an optimization kit covering the broadest range of cell lines cGMP kits available